Masashi Hirooka

Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis

Atsushi Hiraoka, Takashi Kumada, Kunihiko Tsuji et al. · Liver Cancer · 2018 · 245 citations · Full text

Medicine, Oncology, Diagnostic Pathology +15

Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications

Atsushi Hiraoka, Takashi Kumada, Masatoshi Kudo et al. · Liver Cancer · 2017 · 213 citations · Full text

Medicine, Oncology, Clinical Epidemiology +15

A Technique for the Measurement of Visceral Fat by Ultrasonography: Comparison of Measurements by Ultrasonography and Computed Tomography

Masashi Hirooka, Teru Kumagi, Kiyotaka Kurose et al. · Internal Medicine · 2005 · 164 citations · Full text

Medicine, Anatomy, Radiology +14

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis

Atsushi Hiraoka, Takashi Kumada, Masanori Atsukawa et al. · Cancer Medicine · 2019 · 159 citations · Full text

Medicine, Oncology, Pharmacology +13

FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma

Tokuzo Arao, Kazuomi Ueshima, Kazuko Matsumoto et al. · Hepatology · 2012 · 153 citations · Full text

Medicine, Molecular Biology, Oncology +15